ArticleFrontiers in immunology2024

Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.

Tongtong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.